Widespread and Frequent Testing is Essential to Controlling Coronavirus Disease 2019 (COVID-19) in the United States.

Rosenberg, Eli S; Holtgrave, David R

Rosenberg, Eli S; Holtgrave, David R.

Rosenberg ES; Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.
Holtgrave DR; Center for Collaborative Human Immunodeficiency Virus (HIV) Research in Practice and Policy, University at Albany School of Public Health, State University of New York, Rensselaer, New York, USA.

Clin Infect Dis ; 73(9): e2918-e2920, 2021 11 02.

Article in English | MEDLINE | ID: covidwho-1501013

Subject(s)

COVID-19; COVID-19 Testing; Cost-Benefit Analysis; Humans; SARS-CoV-2; United States/epidemiology

Keywords

COVID-19; cost-effectiveness; model; testing

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google